Inhibition of the angiopoietin/Tie2 axis induces immunogenic modulation, which sensitizes human tumor cells to immune attack

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 1 X user

patent: 2 patents

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

METHODS OF USING PEMBROLIZUMAB AND TREBANANIB

Application WO-2019028012-A3

World Intellectual Property Organisation (WIPO)

IMMUNOPOTENTIATOR CONTAINING ANTI-ANG2 ANTIBODY

Application EP-3184543-A3

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.